Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

Z Y Tang1

  • 1Liver Cancer Institute and Zhongshan Hospital, Shanghai Medical University, China. zytang@scrap.stc.sh.cn

Journal of Gastroenterology and Hepatology
|December 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Research progress on the application of ultrasound technology in the diagnosis and treatment of lymphedema].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2026
Same author

[Associations of Life's Crucial 9 and the risk of thyroid dysfunction: a cohort study].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025
Same author

[The application of human genetic technology in the medical field urgently needs standardization].

Zhonghua yi xue za zhi·2024
Same author

[Safety and efficacy of the early administration of levosimendan in patients with acute non-ST-segment elevation myocardial infarction and elevated NT-proBNP levels: An Early Management Strategy of Acute Heart Failure (EMS-AHF)].

Zhonghua nei ke za zhi·2023
Same author

[The legal regulation of medical cosmetology matket should be standardized].

Zhonghua yi xue za zhi·2020
Same author

Cross-cultural adaptation and psychometric evaluation of the Malay version of the Neck Disability Index.

Disability and rehabilitation·2020
Same journal

Patient-Level Predictors of Procedural Success in Colon Capsule Endoscopy: A Systematic Review and Meta-Analysis.

Journal of gastroenterology and hepatology·2026
Same journal

Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality.

Journal of gastroenterology and hepatology·2026
Same journal

Toward the Era of Precision Immunotherapy: The Clinical Landscape and Future Directions of mRNA Vaccines for the Treatment of Hepatocellular Carcinoma.

Journal of gastroenterology and hepatology·2026
Same journal

From Chronic Atrophic Gastritis to Low-Grade Intraepithelial Neoplasia: A Proteomic Study on the Sequential Progression of Gastric Precancerous Lesions.

Journal of gastroenterology and hepatology·2026
Same journal

Resource-Stratified Carbon-Adjusted Quality Indicators for Green Endoscopy.

Journal of gastroenterology and hepatology·2026
Same journal

Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort.

Journal of gastroenterology and hepatology·2026
See all related articles

Early screening for hepatocellular carcinoma (HCC) using alpha fetoprotein (AFP) and ultrasonography reduces mortality. Advances in imaging and therapies like surgical resection and regional cancer treatments are improving HCC prognosis.

Area of Science:

  • Hepatology and Oncology
  • Cancer Research and Treatment

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer death in China and rising globally, particularly in males.
  • Key etiological factors include Hepatitis B and C viruses, aflatoxins, and algal toxins, with other viral agents also under consideration.
  • Improving early diagnosis and treatment strategies are crucial for managing HCC.

Purpose of the Study:

  • To review current advancements in the diagnosis and treatment of hepatocellular carcinoma (HCC).
  • To assess the impact of screening, surgical interventions, and regional therapies on HCC outcomes.
  • To highlight the progress in multimodality treatments and their role in managing unresectable HCC.

Main Methods:

  • Prospective randomized control trials for HCC screening using alpha fetoprotein (AFP) and ultrasonography.

Related Experiment Videos

  • Analysis of surgical resection outcomes, focusing on recurrence and metastasis.
  • Evaluation of regional cancer therapies, multimodality treatments, conformal radiotherapy, and intra-arterial chemotherapy.
  • Review of systemic chemotherapy, hormonal therapy (tamoxifen), and interferon-based treatments.

    • Main Results:

    • Screening high-risk populations with AFP and ultrasonography has shown a decrease in HCC mortality.
    • Surgical resection remains a primary factor influencing HCC prognosis, with ongoing research into recurrence and metastasis.
    • Regional therapies, multimodality approaches, conformal radiotherapy, and intra-arterial chemotherapy demonstrate significant potential.
    • Systemic chemotherapy has yielded disappointing results, while alpha-interferon shows promise, especially in preventing recurrence.

    Conclusions:

    • Early detection through screening and advancements in medical imaging are improving HCC treatment outcomes.
    • Surgical resection, regional therapies, and multimodality treatments are key to enhancing prognosis for HCC patients.
    • Further research into recurrence, metastasis, and novel therapeutic combinations is essential for continued improvement in HCC management.